Clinical Trials Browser

Has results × Small Cell Lung Carcinoma × STA 9090 × Clear all

NCT01173523 2019-04-16

Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

25 enrolled 8 charts

Recurrence, Small Cell Lung Carcinoma

NCT02261805 2018-04-23

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Phase 1/2 Terminated

11 enrolled 7 charts

Neoplasms, Small Cell Lung Carcinoma